Lung-RADS 2022 Calculator

Code a screening low-dose CT by its most suspicious finding. Enter the nodule type, long and short axis (mean diameter to one decimal), and whether it is a baseline, new, growing or stable finding; the calculator applies the November 2022 ACR table, including the stepped management for stable category 3 and 4A nodules.

Disclaimer:

Implements the ACR Lung-RADS v2022 assessment categories (November 2022). For lung-cancer screening exams only; for incidental nodules use the Fleischner calculator. Provided "as is" without warranty of any kind, express or implied, including accuracy, completeness or fitness for a particular purpose. For educational purposes only. The user is solely responsible for verifying results against the source guideline and for all clinical decisions.

Lung-RADS v2022 at a glance

CategoryFindingsManagement
0 IncompletePrior CT being located; lungs not evaluable; findings suggesting infection or inflammationCompare with prior; 1–3 month LDCT for suspected infection
1 NegativeNo nodules, or benign calcification / fat12-month screening LDCT
2 BenignSolid < 6 mm at baseline or new < 4 mm; part-solid < 6 mm at baseline; GGN < 30 mm (any status) or ≥ 30 mm stable / slowly growing; juxtapleural < 10 mm, solid, smooth, oval / lentiform / triangular; subsegmental airway nodule; category 3 stable at 6 months; 4B proven benign12-month screening LDCT
3 Probably benignSolid 6 to < 8 mm at baseline or new 4 to < 6 mm; part-solid ≥ 6 mm with solid component < 6 mm at baseline, or new < 6 mm total; GGN ≥ 30 mm at baseline or new; thick-walled cyst with growing cystic component; 4A stable at 3 months (not airway)6-month LDCT
4A SuspiciousSolid 8 to < 15 mm at baseline, growing < 8 mm, or new 6 to < 8 mm; part-solid with solid component 6 to < 8 mm at baseline, or new / growing solid component < 4 mm; segmental or more proximal airway nodule at baseline; thick-walled or multilocular cyst at baseline, or a cyst that becomes multilocular3-month LDCT; PET/CT may be considered if a solid nodule or component ≥ 8 mm
4B Very suspiciousSolid ≥ 15 mm at baseline, or new / growing ≥ 8 mm; part-solid with solid component ≥ 8 mm at baseline, or new / growing solid component ≥ 4 mm; airway nodule persisting at 3 months; thick-walled cyst with growing wall or nodularity, growing multilocular cyst, or increased loculation / new opacity; slow-growing solid or part-solid noduleDiagnostic chest CT ± contrast, PET/CT if ≥ 8 mm solid, tissue sampling and/or referral
4XCategory 3 or 4 nodule with additional features that increase suspicion (spiculation, lymphadenopathy, metastatic disease, GGN doubling in a year)As 4B
SModifier for a clinically significant finding unrelated to lung cancerPer ACR incidental findings recommendations
  • Mean diameter = (long + short axis) / 2, both measured to one decimal in any plane. Volumes in the ACR table are the equivalent spheres (6 mm = 113 mm³, 8 mm = 268 mm³, 15 mm = 1767 mm³, 30 mm = 14 137 mm³).
  • Growth is > 1.5 mm increase in mean diameter within 12 months. A nodule that crosses a size threshold is reclassified by size even if it does not meet the growth definition.
  • Thin-walled (< 2 mm) unilocular cysts are benign and not classified; a cavitary nodule (wall thickening dominant) is managed as a solid nodule by its total mean diameter.
  • Estimated probability of malignancy per category (< 1 %, 1–2 %, 5–15 %, > 15 %) comes from the Lung-RADS v1.1 / v2022 assessment documents.

References

  1. American College of Radiology. Lung-RADS v2022 Assessment Categories. November 2022. www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Reporting-and-Data-Systems/Lung-RADS
  2. Christensen J, Prosper AE, Wu CC, et al. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations. J Am Coll Radiol. 2024;21(3):473–488. doi:10.1016/j.jacr.2023.09.009